The 11-year long-term follow-up study from the randomized BENEFIT CIS trialLudwig Kappos, Christine Lebrun‐Frénay, Gilles Edan et al.|Neurology|2016Cited by 130
Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and ProgressionMarianna Cortese, Tuula Pirttilä, Xiaojing Peng et al.|Neurology|2025Cited by 3
Consensus d’experts francophones sur la progression insidieuse de la sclérose en plaques : physiopathologie, mesures et besoins non couverts associésDavid Laplaud, Patrick Vermersch, Vito A. G. Ricigliano et al.|Revue Neurologique|2024Cited by 0